EMA and ICMRA urge continuation of COVID-19 vaccine safety trials

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1834卷 / 1期
关键词：
D O I：
10.1007/s40278-020-87193-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 1
相关论文
共 50 条
  • [31] Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts
    Dyer, Owen
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373 : n883
  • [32] COVID-19 vaccine trials with children: ethics pointers
    Atuire, Caesar Alimisnya
    Salas, Sofia P.
    Wright, Katharine
    Ambe, J. Radeino
    de Vries, Jantina
    BMJ GLOBAL HEALTH, 2022, 7 (01):
  • [33] COVID-19 vaccine trials with children: the Jewish ethics
    Rashi, Tsuriel
    BMJ GLOBAL HEALTH, 2022, 7 (03):
  • [34] Covid-19 and EMA Authorized Medicines
    Tesseromatis, C.
    Tounta, D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S57 - S57
  • [35] Safety of seven COVID-19 vaccine booster doses
    Reactions Weekly, 2021, 1885 (1) : 11 - 11
  • [36] Novavax COVID-19 vaccine: no new safety concerns
    Reactions Weekly, 2023, 1971 (1) : 10 - 10
  • [37] Immunogenicity, safety and efficacy of COVID-19 vaccine: Correspondence
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 45
  • [38] Safety and Considerations of the COVID-19 Vaccine Massive Deployment
    Li, Junwei
    Song, Mingyue
    Guo, Deyin
    Yi, Yongxiang
    VIROLOGICA SINICA, 2021, 36 (05) : 1097 - 1103
  • [39] Safety and Considerations of the COVID-19 Vaccine Massive Deployment
    Junwei Li
    Mingyue Song
    Deyin Guo
    Yongxiang Yi
    Virologica Sinica, 2021, 36 (05) : 1097 - 1103
  • [40] Communicating about COVID-19 vaccine development and safety
    Thorpe, Alistair
    Fagerlin, Angela
    Butler, Jorie
    Stevens, Vanessa
    Drews, Frank A.
    Shoemaker, Holly
    Riddoch, Marian S.
    Scherer, Laura D.
    PLOS ONE, 2022, 17 (08):
12345